Scinopharm Taiwan Ltd. (1789)
TWSE
Closed
Aug 25, 2026
Day's Range
18.9552 wk Range
16.70Profile - 1789 - Scinopharm Taiwan Ltd.
Profile
Mic Code
XTAI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
0
Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emphasis on technological innovation and quality control, Scinopharm serves as a crucial entity in the global pharmaceutical supply chain. The company's product portfolio spans a variety of therapeutic categories, including oncology, central nervous system disorders, and cardiovascular diseases. Scinopharm's facilities adhere to international regulatory standards, ensuring the production of APIs that meet stringent quality criteria for both generic and branded pharmaceuticals. With strategic locations in Taiwan and China, the company efficiently caters to the demands of pharmaceutical manufacturers worldwide. Scinopharm's commitment to advanced manufacturing processes and collaborative development projects positions it as a leader in the pharmaceutical manufacturing industry, contributing significantly to enhancing drug availability and accessibility across global healthcare markets.
Profile Details
Type
Common Stock
Ceo
Ms. Li-An Lu
Address
No. 1, Nan-Ke 8th Road
City
Tainan City
Zip
741014
Country
Taiwan
Phone
886 6 505 2888
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
